Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease

被引:14
|
作者
Xu, Chengyan [1 ,2 ]
Ding, Wei [3 ]
Zhang, Minmin [1 ,2 ]
Gu, Yong [1 ,2 ,3 ]
机构
[1] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China
[2] Fudan Univ, Inst Nephrol, Shanghai 200433, Peoples R China
[3] Fudan Univ, Peoples Hosp Shanghai 5, Div Nephrol, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
angiotensin; angiogenesis; chronic kidney disease; EXPRESSION; PROGRESSION; MODULATION; INSIGHTS; FIBROSIS;
D O I
10.1111/nep.12146
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
AimAngiotensin-(1-7) (Ang-(1-7)) opposes angiotensin-II-induced cell growth, matrix accumulation and fibrosis in cardiac tissue. However, the role of Ang-(1-7) in the pathogenesis of renal fibrosis is uncertain. This study observed the effects of Ang-(1-7), on its own or in combination with losartan, an angiotensin-receptor blocker, on five-sixths nephrectomized rats. MethodsMale Sprague-Dawley rats underwent five-sixths nephrectomy, and then were either untreated, treated with Ang-(1-7), treated with losartan, or treated with a combination therapy of Ang-(1-7) and losartan. After 8 weeks, renal function was assessed by measuring systolic blood pressure, serum creatinine and proteinuria. The effect of nephrectomy on the renin-angiotensin system was examined by measuring plasma levels of Ang-II and Ang-(1-7). The extent of glomerulosclerosis and tubulointerstitial fibrosis was assessed by periodic acid-Schiff staining and Masson-trichrome staining. The expression of plasminogen activator inhibitor-1, fibronectin and angiopoietins-Tie-2 was investigated by immunohistochemistry and western blot. ResultsIn the groups of treated rats, serum creatinine, proteinuria and markers of glomerulosclerosis, such as fibronectin and plasminogen activator inhibitor-1, were ameliorated compared with the untreated, nephrectomized rats. Plasma Ang-(1-7) levels were elevated in all treatment groups, but the plasma Ang-II levels were reduced in the Ang-(1-7)-treated group and the combination therapy group. The ratio of Ang-1/Ang-2 was increased in the combination therapy group compared with two other treatment groups. ConclusionAng-(1-7) ameliorated the renal injury of nephrectomized rats. The combination of Ang-(1-7) treatment alongside losartan exerted a superior effect to that of Ang-(1-7) alone on regression of glomerulosclerosis. Summary at a Glance The authors examined the effects of angiotensin-(1-7) (Ang-(1-7)) alone or in combination with angiotensin-receptor blockers using subtotal nephrectomized rats. The results showed that Ang-(1-7) ameliorated the renal injury. The combination of Ang-(1-7) and losartan exerted a superior effect to that of Ang-(1-7) alone on regression of renal injury.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 50 条
  • [31] Angiotensin receptor heterogeneity in the dorsal medulla oblongata as defined by angiotensin-(1-7)
    Diz, DI
    Ferrario, CM
    RECENT ADVANCES IN CELLULAR AND MOLECULAR ASPECTS OF ANGIOTENSIN RECEPTORS, 1996, 396 : 225 - 235
  • [32] ANGIOTENSIN-(1-7) - A NEW HORMONE OF THE ANGIOTENSIN SYSTEM
    FERRARIO, CM
    BROSNIHAN, KB
    DIZ, DI
    JAISWAL, N
    KHOSLA, MC
    MILSTED, A
    TALLANT, EA
    HYPERTENSION, 1991, 18 (05) : S126 - S133
  • [33] Angiotensin-(1-7) and the renin-angiotensin system
    Santos, Robson A. S.
    Ferreira, Anderson J.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2007, 16 (02): : 122 - 128
  • [34] Angiotensin-(1-7), Angiotensin-Converting Enzyme 2 and Mas Receptor in Rat Polycystic Ovaries
    Pereira, Virginia M.
    Reis, Fernando M.
    Casalechi, Maira
    Reis, Adelina M.
    PROTEIN AND PEPTIDE LETTERS, 2021, 28 (03): : 249 - 254
  • [35] ANGIOTENSIN METABOLISM IN RAT STOMACH WALL: PREVALENCE OF ANGIOTENSIN-(1-7) FORMATION
    Olszanecki, R.
    Madej, J.
    Suski, M.
    Gebska, A.
    Bujak-Gizycka, B.
    Korbut, R.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 (01): : 191 - 196
  • [36] Targeting the Protective Arm of the Renin-Angiotensin System: Focused on Angiotensin-(1-7)
    Khajehpour, Sana
    Aghazadeh-Habashi, Ali
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 377 (01): : 64 - 74
  • [37] A Novel Mechanism of Action for Angiotensin-(1-7) via the Angiotensin Type 1 Receptor
    Nicklin, Stuart A.
    HYPERTENSION, 2016, 68 (06) : 1342 - 1343
  • [38] THE ACE2/ANGIOTENSIN-(1-7)/MAS AXIS OF THE RENIN-ANGIOTENSIN SYSTEM: FOCUS ON ANGIOTENSIN-(1-7)
    Souza Santos, Robson Augusto
    Sampaio, Walkyria Oliveira
    Alzamora, Andreia C.
    Motta-Santos, Daisy
    Alenina, Natalia
    Bader, Michael
    Campagnole-Santos, Maria Jose
    PHYSIOLOGICAL REVIEWS, 2018, 98 (01) : 505 - 553
  • [39] Angiotensin-(1-7), a protective peptide against vascular aging
    Valencia, I
    Shamoon, L.
    Romero, A.
    De la Cuesta, F.
    Sanchez-Ferrer, C. F.
    Peiro, C.
    PEPTIDES, 2022, 152
  • [40] Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease
    Beraldo, Juliana Isa
    Benetti, Acaris
    Borges-Junior, Flavio Araujo
    Arruda-Junior, Daniel F.
    Martins, Flavia Leticia
    Jensen, Leonardo
    Dariolli, Rafael
    Shimizu, Maria Heloisa
    Seguro, Antonio C.
    Luchi, Weverton M.
    Girardi, Adriana C. C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)